US 11786603
Optimized transglutaminase site-specific antibody conjugation
granted A61KA61K47/68031A61K47/6883
Quick answer
US patent 11786603 (Optimized transglutaminase site-specific antibody conjugation) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K47/68031, A61K47/6883, A61K47/6889, A61P